Investigators at Johns Hopkins University say they may have found a new way to more accurately predict prostate cancer patients’ prognoses than the current method, which uses disease stage, Gleason score, and PSA levels. 

Continue Reading

John Schieszer reports in today’s Medical Minute that a new technique called TELI-FISH (telomere-specific fluorescent in situ hybridization) may turn out to be an important new tool for urologists.